<DOC>
	<DOCNO>NCT01227603</DOCNO>
	<brief_summary>Randomized , open label , single dose , 4-way crossover study investigate bioequivalence new fix dose combination tablet nifedipine GITS candesartan correspond loose combination compare individual drug</brief_summary>
	<brief_title>Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC ( Fixed Dose Combination ) With Loose Combination Nifedipine GITS ( Gastro-intestinal Therapeutic System ) Plus Candesartan Single Components Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>Healthy male subject Age : 18 45 year ( inclusive ) first screen / examination visit Ethnicity : Caucasian Body mass index ( BMI ) : &gt; /=18 &lt; /=29,9 kg/mÂ² Systolic blood pressure 120 145 mmHg Diastolic blood pressure 95 mmHg Heart rate 45 95 beat / min Clinically relevant finding physical examination Suspicion drug alcohol abuse Regular daily consumption 1 L xanthincontaining beverage Intake food beverage contain grapefruit within 4 week prestudy examination</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Nifedipine</keyword>
	<keyword>Candesartan</keyword>
	<keyword>FDC</keyword>
</DOC>